Dosage and potency information: Details on formulation, usage scenarios, and additional facts
Idhifa, a brand-name drug, has been approved by the FDA for treating acute myeloid leukemia (AML) in adults. This drug belongs to a class called IDH2 inhibitors, which target specific mutations in AML cells.
Idhifa is an oral tablet, available in strengths of 50 milligrams (mg) and 100 mg. The typical dosage for AML is 100 mg, taken once per day. It's important to note that the dosage can vary depending on factors such as how the body responds to the drug, other medications taken, and side effects experienced. Always follow the dosage that your doctor prescribes for Idhifa.
Taking Idhifa involves swallowing the tablet whole, not chewing or splitting it. It should be taken with 1 cup (8 ounces) of water, and it may be helpful to take it around the same time of day for consistent dosing.
Idhifa is specifically indicated for relapsed or refractory AML with an IDH2 mutation confirmed by an FDA-approved test. This means that the drug is intended for AML that has come back after treatment or has not responded to treatment and has this particular mutation.
As with any medication, it's crucial to monitor for side effects when taking Idhifa. However, the consistent daily dosing schedule supports steady-state drug levels for optimal efficacy in targeting the mutant IDH2 enzyme in AML cells.
If you miss a dose of Idhifa, take it as soon as you remember on the same day. If you vomit a dose of Idhifa, you can take a second dose on the same day. For information about other aspects of Idhifa, such as its comparison with other drugs, refer to this article.
In case of overdose, call America's Poison Centers at 800-222-1222 or use its online tool. It's essential to remember that Idhifa is not available in a generic version, so always discuss other treatment options with your doctor.
Idhifa and Venclexta are both oral tablets prescribed for AML and are taken once per day, but their doses differ. If you take more than the recommended amount of Idhifa, call your doctor right away. Idhifa is meant to be taken as long as it works to treat the condition without causing serious side effects.
In summary, the FDA-approved and widely accepted dose for Idhifa in adults with AML is 100 mg orally once daily. Always follow the dosage prescribed by your doctor when taking Idhifa.
